NFKB1 and prostate carcinoma: Moreover, other investigators showed that PIs can decrease proliferation of Kaposi sarcoma as well as prostate cancer cells via inhibition of NF-κB activity (Pajonk et al, 2002; Pati et al, 2002; Sgadari et al, 2002).